- Home
- PRQR vs ISPR Comparison
PRQR vs ISPR Comparison
Compare PRQR & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- ISPR
- Stock Information
- Founded
- PRQR 2012
- ISPR 2010
- Country
- PRQR Netherlands
- ISPR United States
- Employees
- PRQR N/A
- ISPR N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- PRQR Health Care
- ISPR Health Care
- Exchange
- PRQR Nasdaq
- ISPR Nasdaq
- Market Cap
- PRQR 224.4M
- ISPR 126.0M
- IPO Year
- PRQR 2014
- ISPR 2023
- Fundamental
- Price
- PRQR $2.78
- ISPR $2.43
- Analyst Decision
- PRQR Strong Buy
- ISPR Strong Buy
- Analyst Count
- PRQR 8
- ISPR 1
- Target Price
- PRQR $8.88
- ISPR $7.50
- AVG Volume (30 Days)
- PRQR 624.3K
- ISPR 49.6K
- Earning Date
- PRQR 11-06-2025
- ISPR 11-10-2025
- Dividend Yield
- PRQR N/A
- ISPR N/A
- EPS Growth
- PRQR N/A
- ISPR N/A
- EPS
- PRQR N/A
- ISPR N/A
- Revenue
- PRQR $20,129,184.00
- ISPR $127,494,304.00
- Revenue This Year
- PRQR N/A
- ISPR $60.96
- Revenue Next Year
- PRQR N/A
- ISPR $23.96
- P/E Ratio
- PRQR N/A
- ISPR N/A
- Revenue Growth
- PRQR 8.65
- ISPR N/A
- 52 Week Low
- PRQR $1.07
- ISPR $2.06
- 52 Week High
- PRQR $4.62
- ISPR $7.47
- Technical
- Relative Strength Index (RSI)
- PRQR 67.47
- ISPR 46.11
- Support Level
- PRQR $2.20
- ISPR $2.06
- Resistance Level
- PRQR $2.58
- ISPR $2.45
- Average True Range (ATR)
- PRQR 0.22
- ISPR 0.19
- MACD
- PRQR 0.05
- ISPR 0.01
- Stochastic Oscillator
- PRQR 77.54
- ISPR 52.56
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.